SLC6A3 and Parkinson disease: In a combined [123I]β-CIT-SPECT study, Berendse et al. (2001) have shown a sub-clinical abnormal reduction in striatal dopamine transporter binding in asymptomatic PD patients’ relatives with quantitative olfactory dysfunction (Berendse et al., 2001).